VKTX - UP TO 97% WEIGHT LOSS MAINTAINED WITH EVERY-OTHER-WEEK DOSING FOR THREE MONTHS

Viking Therapeutics NASDAQ:VKTX said patients shifted to a less frequent dosing regimen of its experimental obesity treatment showed superior weight loss maintenance in a study than those on placebo, sending its shares up 40% before the bell.The company said on Tuesday that patients who switched to…